Found 115 matching trials
Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy PHASE4 That anti-TNF therapy and rituximab therapy are equally effective in treati...
Show More Learn More & Join Trial
Stopping TNF Alpha Inhibitors in Rheumatoid Arthritis PHASE4 Background:
* Rheumatoid arthritis (RA) is often treated with drugs known ...
Show More Location
Georgetown University Medical Center
Learn More & Join Trial
The HAM Infliximab Study PHASE2 An open-label, non-randomised, uncontrolled, proof-of-concept study of eigh...
Show More Location
Imperial College Healthcare NHS Trust
Learn More & Join Trial
Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success N/A The primary goal of the study is to develop an early (within 4 weeks) combi...
Show More Location
University Hospital Bern Inselspital
Learn More & Join Trial
CHronic Nonbacterial Osteomyelitis International Registry N/A The objective of the study is to establish a prospective disease registry f...
Show More Location
Seattle Children's Hospital
Learn More & Join Trial
Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis N/A This is an open-label, prospective, observational study with the primary ob...
Show More Status
Active Not Recruiting
Learn More & Join Trial
An Observational Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis And Inadequate Response Or Intolerance to a First Anti-TNF Alpha Therapy N/A This prospective, multi-center, observational study will evaluate the effic...
Show More Location
Multiple Locations
Learn More & Join Trial
Longitudinal ULtrasonographic Study of Patients With Spondylarthritis Starting Biological Therapy N/A Patients with spondylarthritis (SpA) (including ankylosing spondylitis, pso...
Show More Location
Department of Rheumatology, Diakonhjemmet Hospital
Learn More & Join Trial
A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma PHASE1 This is a first in human, open-label, dose escalation and expansion Phase 1...
Show More Location
Henry Ford Health
Learn More & Join Trial
Safety of TofAcitinib in Routine Care Patients With Rheumatoid Arthritis (STAR-RA)- Cardiovascular Endpoints N/A There are two main aims of this study.
First aim is to compare the risk of...
Show More Location
Brigham And Women's Hospital
Learn More & Join Trial